Activity and tolerability of the Bruton's tyrosine kinase (Btk) inhibitor PCI-32765 in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Interim results of a phase Ib/II study.
J. C. Byrd
Research Funding - Pharmacyclics
K. A. Blum
Research Funding - Pharmacyclics
J. A. Burger
Research Funding - Pharmacyclics
S. E. Coutre
Research Funding - Pharmacyclics
J. P. Sharman
Honoraria - Pharmacyclics
R. R. Furman
Research Funding - Pharmacyclics
I. W. Flinn
Research Funding - Pharmacyclics
B. W. Grant
Research Funding - Pharmacyclics
D. A. Richards
Research Funding - Pharmacyclics
W. Zhao
Research Funding - Pharmacyclics
N. A. Heerema
Research Funding - Pharmacyclics
A. J. Johnson
Research Funding - Pharmacyclics
R. Izumi
Employment or Leadership Position - Pharmacyclics
Stock Ownership - Pharmacyclics
A. Hamdy
Employment or Leadership Position - Pharmacyclics
Stock Ownership - Pharmacyclics
S. M. O'Brien
Research Funding - Pharmacyclics